NEW YORK ( TheStreet) -- Ariad Pharmaceuticals (Nasdaq: ARIA) hit a new 52-week high Friday as it is currently trading at $16.83, above its previous 52-week high of $16.75 with 1.4 million shares traded as of 11:15 a.m. ET. Average volume has been 3.4 million shares over the past 30 days. Ariad has a market cap of $2.59 billion and is part of the health care sector and drugs industry. Shares are up 34.9% year to date as of the close of trading on Thursday. ARIAD Pharmaceuticals, Inc., an oncology company, focuses on the discovery, development, and commercialization of medicines for cancer patients.
- Sign up for TheStreet's FREE Dividend and Income Investor Newsletter